Upload
others
View
7
Download
0
Embed Size (px)
Citation preview
Complexes de lanthanides pour la biologie structurale
Porquerolles, 10-12 Octobre 2018
François Riobé
Chemistry for optics team
2
Chem. Eur. J., 2017
Luminescent materials
Functional bioprobes
Link luminescence ↔ magnetism
LnIII
Chelating ligand
Energy transfer Emission
Excitation
Protein crystallography
J. Am. Chem. Soc., 2017
In preparation
3D structure of proteins• Up to 11.000 structures a year
• NMR (9%)• requires an enrichment N15 C13
• Crystallography (90%)• Direct access to the structure• Needs diffracting crystals• Solving the phase problem… 3
1985 1990 1995 2000 2005 2010 20150
20000
40000
60000
80000
100000
120000
140000
Stru
ctur
es
Total Yearly
X-RAYNMRELECTRON MICROSCOPYHYBRIDother
source: RCSB Protein Data Bank, May 2017
ESRF, Grenoble, FRANCE
Challenges in crystallography of proteins• Only 27 % of purified soluble proteins give diffracting crystals
4
0
10000
20000
30000
40000
50000
60000
70000
purified crystallized diffractingcrystals
crystalstructures
Source: PSI Structural Biology Knowledgebase, May 2016
Standardization of crystallization conditions
Robotized crystallization platforms
Crystallization platforms and large instruments• More efficient light sources
• Automation of the collect
• Towards high-throughput crystallization projects• Looking for extreme environment (pressure, µgravity...)
5
European XFEL
Crystallization platforms and large instruments• More efficient light sources
• Automation of the collect
• Towards high-throughput crystallization project• Looking for extreme environment (pressure, µgravity...)
6
European XFEL
Thomas Pesquet handling protein crystallization facility hardware on the ISS for a crystallization investigation by Merck & Co.
Challenges in crystallography of proteins• Only 27 % of purified soluble proteins give diffracting crystals
• 50 % of diffracting crystals allow structure determination
• In the end, only 10% of protein structures are determined
7
0
10000
20000
30000
40000
50000
60000
70000
purified crystallized diffractingcrystals
crystalstructures
Source: PSI Structural Biology Knowledgebase, May 2016
“phase problem”
Solving the phase problem
• Anomalous scattering from heavy elements in the structure
• Selenation of methionine residues• Requires purification and crystallization of the selenated protein• Tedious and time consuming method
• Introduction of a lanthanide• By cocrystallization or soaking of a Ln salt
• Strong anomalous signal• May change or even destroy the 3D structure
• Use of MRI contrast agents
8
J. Reuben, Naturwissenschaften1975, 62, 172 – 178.
coll. E. Girard, R. Kahn
Lanthanide complexes for anomalous scattering
• Luminescent lanthanide complexes
• Co-crystals obtained with HEWL
9
[Tb(DPA)3]3-
Sensitization of terbium (II)through ligand absorption
[Tb] et [Eu]@HEWL under UV light
[Tb(DPA)3]3- HEWL co-crystalAngew. Chem. Int. Ed. 2008, 47, 3388
Supramolecular binding
10Specific supramolecular interactions with arginine residues
NH
*NH
N
N
O
O
H H
H
HProtein
N
O O
OO
LnN
OO
OO
NO
OO
O3
Phys. Chem. Chem. Phys., 2013,15, 18235.
Collab. E. Dumont (ENS Lyon)N. Giraud (ICMMO, Paris Sud)
Instability of [Ln(DPA)3]3- in screening kits
11
C84H140Ca6Eu4N12O100
Alcaline-earths Transition metals
Neutral complex
low solubility in water no electrostatic interaction
with proteins
N
N
OO
N NO
O
N
N
O
O
Tb
neutral
Instability of [Ln(DPA)3]3- in screening kits
12
C84H140Ca6Eu4N12O100
Alcaline-earths Transition metals
N
N
OO
N
N
N
O
O
Tb
H
+
Cl-
Charged: 1+Inner coordination sphere incomplete
High solubility Affinity towards negatively charged areas? Recognition of carboxylate?
Effet Nucleating effect
13
HEWL (129AA) crystallisation diagrams
native conditions
After 2 days
clear drop crystals
Nucleating effect
14
HEWL (129AA) crystallisation diagrams
native conditions with 10 mM of Tb-XO4
After 2 days
clear drop crystals
Nucleating effect
15
HEWL (129AA) crystallisation diagrams
native conditions with 10 mM of Tb-XO4
After 2 days
After 20 days
clear drop crystals
Nucleating effect• Test panel of 8 proteins
16
Nucleating effect• Comparative experiment without (native) and with 10 mM Xo4
• 6 crystallization screens for 576 conditions:• PEGs-I Quiagen• Salt-grid HR,• Wizard I-II Rigaku• PACT MD • CSG MD • Classics Suite Qiagen
• Screening performed at the HTX-Lab platform (EMBL-Grenoble)
• 100 nL of protein solution with 100 nL of precipitant solution
17
Nucleating effect
18
• Number of crystallization hits over 576 conditions after 34 days
Nucleating effect
19• Xo4 provides new unique conditions!
Shared conditions
Native conditions only
Xo4 unique conditions
Nucleating effect
20
MDH pb9
+ Xo4
native native
+ Xo4
• Xo4 provides new unique conditions!
Chem. Sci. 2017, 8, 5909-5917.
Nucleating effect
• Results after 7 days: clear drop crystals precipitate
• Xo4 allows crystal growth at low protein concentration• At 5 mg/mL, crystals are ready to use for X-ray diffraction
21
Pb6: shared crystallization condition HEPES pH 7.5 100 mM / PEG 6000 11 to 16 %
native conditions with 10 mM of Tb-XO4
Chem. Sci. 2017, 8, 5909-5917.
2 complexes per monomerOccupancy after soaking 100 mM
Tb1: 0.8Tb2: 0.3
Direct coordination with Asp 101 (-15 kcal.mol-1)Hydrophobic cage Trp 62 and 123 (-20 kcal.mol-1 each)
Binding sites: HEWL
22
Chem. Eur. J. 2018, 24, 9739-9746.
Binding sites: Protease 1 Protease 1 from P. Horikhoshiicrystallized in sulfate buffer
23
166 AA per monomer3 monomers in the ASU1 complex per monomer
1 complex per monomer The complex is “neutralised” by a SO4
2-
Interaction with Glu 36, Phe 35 and Arg 75No direct coordination with Asp or Glu
Chem. Eur. J. 2018, 24, 9739-9746.
Binding sites: Protease 1 Protease 1 from P. Horikhoshiicrystallized in sulfate buffer
24
166 AA per monomer3 monomers in the ASU1 complex per monomer
The buffer influence the binding efficiency but not the nucleation ability
Chem. Eur. J. 2018, 24, 9739-9746.
Binding sites: FprA
25
1 site with a full occupancy.
Coordination of Asp 113 on Tb (-24 kcal.mol-1) H-bonding of Gua 399 with a picolinate (-19 kcal.mol-1) interaction of Tyr 382 with pyridine (-16 kcal.mol-1
Multiple and complementary interactions
Unique condition in presence of Tb-Xo4
Seeking new nucleating agents
26
N
N
N
NN
N NNN
HTb
+
Cl-
N N
NN N
N
P
N
NP N
HTb
+
Cl-
MeOO
OMe
O
no effectweak effect
moderate nucleation effect
Patent No. PCT/FR2016/053539
Luminescence properties
• MDH crystallization:
• Protein crystal detection• Discrimination from salt crystals• Could be helpful for crystal centering on the
beamline 27UV led and optical fiber
Salt crystal MDH crystals
under UVunder UV
Seeking new nucleating agents
28
Screening of HEWL with 10 mM of Tb-Xo4 (unique conditions)
Seeking new nucleating agents
29
Same screening with 10 mM of Lu-Xo4
How does it promote nucleation?
Phasing sites only partially relevant Low occupancies upon nucleation conditions (low concentration) Only few crystallographic sites are clearly responsible of an overall
stabilization of the packing Informative to understand interactions prot./complex
Interactions in solution?paramagnetic H-NMR and Dosy-NMRDLS/SAXS
Hypothesis Reduction of surface entropy Stabilization of dangling chains Crystallization of mutants
Localized and versatile screening of repulsive interactions30
Funding:
Sebastiano Di PietroSandrine Denis-QuanquinDelphine PitratJean-Christophe MulatierElise DumontOlivier Maury
Sylvain EngilbergeLouise LassalleCécile BreytonCharles ArnaudEric Girard
Nicolas Giraud
Chemistry for Optics team
Ln23 project31